MicroRNA-195 liposomes for therapy of Alzheimer's disease-Reference-Cited by-同舟云学术

MicroRNA-195 liposomes for therapy of Alzheimer's disease

Published:2024-01 Issue: Volume:365 Page:583-601
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Su Dan,Chen Zhong,An Xiaobin,Yang Junkai,Yang Jinan,Wang Xuqiao,Qu Yang,Gong Chen,Chai Yani,Liu Xiaoying,Cheng Wei,Wang Dongyang,Wu Yan,Ma Jing,Zhao Xinyue,Wang Qin,Xu Yun,Peng Haisheng,Ai Jing

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference62 articles.

1. A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease;Panza;Nat. Rev. Neurol.,2019

2. Immunotherapy for Alzheimer’s disease;Dodel;Lancet Neurol.,2003

3. Therapeutic strategies for Alzheimer’s disease in clinical trials;Godyn;Pharmacol. Rep.,2016

4. Donepezil for dementia due to Alzheimer’s disease;Birks;Cochrane Database Syst. Rev.,2018

5. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease;Hampel;Brain,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability;Advanced Science;2024-08-05

2. Dual-modified brain-targeting lipid polymer micelle delivery of anti-miRNA-21 for achieving oral treatment of glioma;Journal of Drug Delivery Science and Technology;2024-06

3. Regulatory roles of microRNAs in modulating mitochondrial dynamics, amyloid beta fibrillation, microglial activation, and cholinergic signaling: Implications for alzheimer's disease pathogenesis;Neuroscience & Biobehavioral Reviews;2024-06